Correlation of the Chemoresponse Assay With PFS in Patients With Recurrent Epithelial Ovarian, Peritoneal, or Fallopian Tube Cancer
Public ClinicalTrials.gov record NCT00288275. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Non-Interventional Prospective Study of the Correlation of the Precision Therapeutics, Inc. Chemoresponse Assay With Progression-Free Survival in Patients With Recurrent Epithelial Ovarian, Peritoneal, or Fallopian Tube Cancer.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Chemoresponse assays (lab test) measure the effect that chemotherapy treatment has on a patient's cancer cells in the lab. This test has shown success in a retrospective study in predicting how an individual patient's tumor will respond to a given chemotherapy and how treatment utilizing an agent that the test said that a patient's cells would be sensitive too corresponds to a longer progression free interval. This study will determine the ability of two tests used to predict the success of chemotherapy in recurrent, persistent, or refractory cancer of the ovaries, fallopian tube(s) or peritoneum by measuring how long patients live without progression.
Study identification
- NCT ID
- NCT00288275
- Recruitment status
- Terminated
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 256 participants
Conditions and interventions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 2004 (Type not available)
- Primary completion
- Not listed
- Completion
- Oct 2012 (Actual)
- Last update posted
- Oct 5, 2012
2004 – 2012
United States locations
- U.S. sites
- 36
- U.S. states
- 21
- U.S. cities
- 33
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of California | Irvine | California | 92868 | — |
| Kaiser Permanente | Los Angeles | California | 90027 | — |
| Yale University Medical Center | New Haven | Connecticut | 06520 | — |
| Florida Gynecologic Oncology | Fort Myers | Florida | 33901 | — |
| St. Vincents Medical Center | Jacksonville | Florida | 32204 | — |
| The Florida Hospital | Orlando | Florida | 32804 | — |
| Women's Cancer Associates | St. Petersburg | Florida | 33701 | — |
| Atlanta Medical Center | Atlanta | Georgia | 30312 | — |
| Southeastern Gynecologic Oncology Riverdale | Riverdale | Georgia | 30274 | — |
| Northwestern University/Prentice Women's Hospital | Chicago | Illinois | 60611 | — |
| Rush University | Chicago | Illinois | 60612 | — |
| St. Vincent Indianapolis Hospital | Indianapolis | Indiana | 46260 | — |
| St. Elizabeth Medical Center | Edgewood | Kentucky | 41017 | — |
| University of Minnesota | Minneapolis | Minnesota | 55455 | — |
| Washington University | St Louis | Missouri | 63110 | — |
| Saint Louis University | St Louis | Missouri | 63117 | — |
| The Cooper Health System | Camden | New Jersey | 08103 | — |
| Saint Barnabas Medical Center | West Orange | New Jersey | 07052 | — |
| Schwartz Gynecologic Oncology, PLLC | Brightwaters | New York | 11718 | — |
| University of Cincinnati Medical Center Barrett Cancer Center | Cincinnati | Ohio | 45219 | — |
| University Hospital Case Medical Center | Cleveland | Ohio | 44106 | — |
| Cleveland Clinic | Cleveland | Ohio | 44195 | — |
| University of Toledo Medical Center | Toledo | Ohio | 43614 | — |
| University of Oklahoma Health Sciences Center | Oklahoma City | Oklahoma | 73190 | — |
| Legacy Health System | Portland | Oregon | 97227 | — |
| Abington Memorial Hospital | Abington | Pennsylvania | 19001 | — |
| UPMC Cancer Center at Magee Womens Hospital | Pittsburgh | Pennsylvania | 15213 | — |
| Lankenau Hospital, Mainline Health System | Wynnwood | Pennsylvania | 19096 | — |
| Women & Infants Hospital | Providence | Rhode Island | 02905-2499 | — |
| Cancer Centers of the Carolinas | Greenville | South Carolina | 29605 | — |
| ACORN - The West Clinic | Memphis | Tennessee | 38138 | — |
| Vanderbilt-Ingram Cancer Center | Nashville | Tennessee | 37232 | — |
| UT Southwestern Medical Center | Dallas | Texas | 75390 | — |
| The Methodist Hospital | Houston | Texas | 77030 | — |
| University of Virginia Health System | Charlottesville | Virginia | 22908 | — |
| University of Wisconsin, Madison | Madison | Wisconsin | 53715 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00288275, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 5, 2012 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00288275 live on ClinicalTrials.gov.